Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4061 USD | +0.15% | +1.63% | -93.94% |
04-16 | GRI Bio Receives South Korea Patent for Liver Inflammatory Condition Treatments | MT |
2023 | Vallon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration- Stock Market
- Equities
- GRI Stock
- News GRI BIOPAR
- HC Wainwright Starts Vallon Pharmaceuticals at Buy With $12 Price Target